Valuation: MediPal Holdings Corporation

Market Cap 704B 4.47B 4.01B 3.69B 3.34B 6.24B 424B 6.36B 43.58B 17.55B 223B 16.78B 16.42B P/E 2027 *
13.6x
P/E 2028 * 14.6x
Enterprise Value 704B 4.47B 4.01B 3.69B 3.34B 6.24B 424B 6.36B 43.58B 17.55B 223B 16.78B 16.42B EV / Sales 2027 *
0.18x
EV / Sales 2028 * 0.17x
Free-Float
87.33%
Yield 2027 *
2.17%
Yield 2028 * 2.4%
1 day+1.99%
1 week+7.33%
Current month+16.37%
1 month+16.37%
3 months+14.62%
6 months+22.50%
Current year+24.22%
1 week 3,258
Extreme 3258
3,449
1 month 2,904.5
Extreme 2904.5
3,449
Current year 2,530
Extreme 2530
3,449
1 year 2,456.5
Extreme 2456.5
3,449
3 years 2,156
Extreme 2156
3,449
5 years 1,603
Extreme 1603
3,449
10 years 1,426
Extreme 1426
3,449
Manager TitleAgeSince
Chief Executive Officer 65 30/09/2026
Chief Administrative Officer - 31/05/2025
Corporate Officer/Principal 69 31/05/2025
Director TitleAgeSince
Director/Board Member 63 31/05/2010
Director/Board Member 71 31/05/2007
Director/Board Member 54 31/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.99%+7.33%+36.82%+40.71% 4.47B
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +2.07%+6.04%+45.61%+78.90% 426.64B
Weighted average by Cap. +2.01%+6.60%+50.87%+98.25%

Financials

2027 *2028 *
Net sales 3,941B 25B 22.41B 20.63B 18.68B 34.93B 2,375B 35.57B 244B 98.17B 1,250B 93.88B 91.88B 4,055B 25.72B 23.06B 21.23B 19.22B 35.94B 2,443B 36.59B 251B 101B 1,286B 96.59B 94.53B
Net income 51.54B 327M 293M 270M 244M 457M 31.06B 465M 3.19B 1.28B 16.35B 1.23B 1.2B 45.74B 290M 260M 240M 217M 405M 27.57B 413M 2.83B 1.14B 14.51B 1.09B 1.07B
Net Debt - -
Projected Income Statement - Annual - MediPal Holdings Corporation
Logo MediPal Holdings Corporation
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
Employees
13,024
Date Price Change Volume
30/10/26 JP¥3,441.00 +1.99% 468,900
29/10/26 JP¥3,374.00 +0.69% 848,200
28/10/26 JP¥3,351.00 -2.39% 465,100
27/10/26 JP¥3,433.00 +1.09% 608,600
26/10/26 JP¥3,396.00 +5.93% 771,900
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - MediPal Holdings Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3,441.00JPY
Average target price
3,145.00JPY
Spread / Average Target
-8.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MediPal Holdings Corporation
  1. Stock Market
  2. Stocks
  3. 7459 Stock